Debenhams Group - About the company
Debenhams Group is an unfunded company based in Manchester (United Kingdom), founded in 2006. It operates as a Developer of artificial intelligence platforms for pharmaceutical drug discovery research. Debenhams Group has not raised any funding yet. The company has 268 active competitors, including 82 funded and 15 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics.
Company Details
Developer of artificial intelligence platforms for pharmaceutical drug discovery research. This technology integrates large biological and chemical datasets with automated laboratory robotics and computer vision to identify new disease targets and design therapeutic molecules. The platform facilitates the development of treatments for oncology and rare conditions by training machine learning models to analyze cellular disruptions. These digital and physical tools support the identification and optimization of drug candidates throughout the preclinical and clinical trial phases.
- Website
- www.debenhamsgroup.com/
- Email ID
- *****@debenhamsgroup.com
Key Metrics
Founded Year
2006
Location
Manchester, United Kingdom
Stage
Unfunded
Ranked
104th among 268 active competitors
Employee Count
8,809 as on Sep 30, 2026
Similar Companies
Sign up to download Debenhams Group's company profile
Debenhams Group's funding and investors
Debenhams Group has not raised any funding rounds yet.
Debenhams Group's founders and board of directors
Founder? Claim ProfileDebenhams Group's employee count trend
Debenhams Group has 8,809 employees as of Sep 26. Here is Debenhams Group's employee count trend over the years:
Uncover Debenhams Group's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Debenhams Group's Competitors and alternates
Top competitors of Debenhams Group include Schrodinger, Recursion Pharmaceuticals and Relay Therapeutics. Here is the list of Top 10 competitors of Debenhams Group, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Schrodinger 1990, New York City (United States), Acquired | Provider of a web-based simulation and modelling tool | $162M | 74/100 | |
2nd | Recursion Pharmaceuticals 2013, New York (United States), Public | AI-enabled drug discovery and development platform for novel therapeutics | $452M | 72/100 | |
3rd | Relay Therapeutics 2016, Cambridge (United States), Public | Developer of drug discovery platform and study protein motion | $520M | 70/100 | |
4th |  Atomwise 2012, San Francisco (United States), Series B | Developer of artificial intelligence platform for small molecule drug discovery | $219M | 67/100 | |
5th |  Valo Health 2019, Boston (United States), Series B | AI-powered platform for drug discovery and development | $450M | 67/100 | |
6th |  XtalPi 2014, Cambridge (United States), Public | AI-based drug research and development company | $785M | 67/100 | |
7th |  Xaira 2023, San Francisco (United States), Series D | AI-enabled platform for drug discovery and development | $1B | 63/100 | |
8th |  In Silico 2014, Boston (United States), Public | AI-enabled bioinformatics platform for drug discovery and biomarker development | $510M | 62/100 | |
9th |  Tandem AI 2021, New York (United States), Series A | AI-based drug discovery tool for researchers | $82M | 62/100 | |
10th | Healx 2014, Cambridge (United Kingdom), Series C | Provider of AI-powered drug discovery solutions for rare diseases | $115M | 62/100 | |
104th | Debenhams Group 2006, Manchester (United Kingdom), Unfunded | Developer of artificial intelligence platforms for pharmaceutical drug discovery research | - | - | 31/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Debenhams Group's competitors? Click here to see the top ones
Debenhams Group's Investments and acquisitions
Debenhams Group has made no investments or acquisitions yet.
Reports related to Debenhams Group
Here is the latest report on Debenhams Group's sector:
News related to Debenhams Group
Filter this listMedia has covered Debenhams Group for a total of 22 events in the last 1 year, 6 of them have been about company updates and 3 about people movement.
•
Debenhams Group names new chair and adds two non-executive directorsThe Retail Bulletin•Sep 18, 2026•Debenhams Group
•
WSG Brands Acquires Nasty Gal to Accelerate Growth and Global ExpansionPR Newswire•Sep 16, 2026•WSG Brands, Nasty Gal, Debenhams Group, Fashion Network and 2 others
•
Debenhams sells Sheffield distribution centre to Primark for £90mThe Retail Bulletin•Sep 10, 2026•Primark, Debenhams Group, Associated British Foods, Debenhams
•
•
•
Debenhams Group Reports Q1 Growth and Recovery in PrettyLittleThing PerformanceFashion Network•Jun 03, 2026•Debenhams Group
•
Debenhams Group appoints Paul Aspden as chief technology officerThe Retail Bulletin•Apr 20, 2026•Debenhams Group
•
Tattersall joins Debenhams Group from ASOS to lead youth brands product strategyFashion Network•Apr 15, 2026•Debenhams Group
•
•
Debenhams Group powers past guidance as marketplace pivot pays offRetail Gazette•Mar 30, 2026•Debenhams Group
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Debenhams Group
Explore our recently published companies
- Bayview Roofing - Hyde Park based, Unfunded company
- Malispace - Unfunded company
- Morey Carpentry - Canada based, 2009 founded, Unfunded company
- Hult Founders Lab - Cambridge based, 2003 founded, Unfunded company
- Glass Repair Services - Oakville based, Unfunded company
- Stay Dry Roofing - Toronto based, Unfunded company
